Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MORIGI, M.
Right arrow Articles by REMUZZI, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MORIGI, M.
Right arrow Articles by REMUZZI, G.
J Am Soc Nephrol 10:2197-2207, 1999
© 1999 American Society of Nephrology

Xenogeneic Serum Promotes Leukocyte-Endothelium Interaction under Flow through Two Temporally Distinct Pathways

Role of Complement and NuclearFactor-{kappa}B

MARINA MORIGI*, CARLA ZOJA*, STELLA COLLEONI*, STEFANIA ANGIOLETTI*, BARBARA IMBERTI*, ROBERTA DONADELLI*, ANDREA REMUZZI* and GIUSEPPE REMUZZI*,{dagger}

* Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
{dagger} Division of Nephrology and Dialysis, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy.

Correspondence to Dr. Marina Morigi, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy. Phone: +39 035 319888; Fax: +39 035 319331; E-mail: Morigi{at}irfmn.mnegri.it

Abstract. Endothelial cell activation and mononuclear cell infiltration are consistent features of discordant xenograft rejection. This study evaluated whether xenogeneic serum—as a source of xenoreactive natural antibodies and complement—induced endothelial activation with consequent leukocyte adhesion and transmigration under flow conditions. Porcine aortic endothelial cells (PAEC) were incubated for 30 min, 1 h 30 min, or 5 h with 10% human serum or 10% porcine serum and then perfused with human leukocytes in a parallel plate flow chamber under flow (1.5 dynes/cm2). Adherent and transmigrated cells were counted by digital image analysis. Results showed that human serum significantly (P < 0.01) increased over time the number of adherent leukocytes compared with porcine serum. Stimulation of PAEC with human serum also promoted a progressive increase in leukocyte transmigration that reached statistical significance (P < 0.01) at 1 h 30 min and at 5 h compared with porcine serum. Studying the role of complement in leukocyte-endothelium interaction in xenogeneic conditions, a marked complement C3 deposition on PAEC exposed to human serum was shown by immunofluorescence, whereas cells incubated with procine serum were negative. Next, it was documented that human serum decomplemented by heating and C3-deficient human serum failed to promote both leukocyte adhesion and transmigration, results that were comparable to porcine serum. To elucidate the intracellular mediators involved in endothelial cell activation by xenogeneic serum, this study focused on transcriptional factor nuclear factor-{kappa}B (NF-{kappa}B), a central regulator for the induction of different genes, including adhesive molecules and chemoatractants. Positive nuclear staining of NF-{kappa}B (p65 subunit) found by confocal fluorescence microscopy of PAEC exposed to human serum was taken to reflect NF-{kappa}B activation. NF-{kappa}B was instead strictly localized in the cell cytoplasm in PAEC incubated with the homologous serum. Heat-inactivated human serum failed to activate NF-{kappa}B. Electrophoretic mobility shift assay of nuclear extracts from PAEC exposed to human serum revealed an intense NF-{kappa}B activation that was inhibited by the NF-{kappa}B inhibitor pyrrolidinedithiocarbamate. The NF-{kappa}B inhibitors pyrrolidinedithiocarbamate and tosyl-phe-chloromethylketone did not affect the number of adherent and transmigrated leukocytes in PAEC exposed to human serum for 30 min and 1 h 30 min. Both inhibitors instead significantly reduced leukocyte adhesion and transmigration induced by human serum at 5 h. Confocal fluorescence microscopy studies showed that human serum induced an increase in the expression of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1. Functional blocking of these adhesive molecules with the corresponding antibodies significantly inhibited xenogeneic serum-induced leukocyte adhesion. These data suggest that leukocyte adhesion and transmigration are directly dependent on complement deposited on PAEC in the early phase of cell activation (30 min and 1 h 30 min) induced by xenogeneic serum, whereas leukocyte adhesive events observed after 5 h of incubation of endothelial cells with xenogeneic serum are possibly regulated by transcription of NF-{kappa}B-dependent genes. The finding that xenogeneic serum promotes leukocyte-endothelial interaction depending on NF-{kappa}B activation might be relevant for designing future therapeutic strategies intended to prolong xenograft survival.




This article has been cited by other articles:


Home page
Circ. Res.Home page
G. Boulday, S. Coupel, F. Coulon, J.-P. Soulillou, and B. Charreau
Antigraft Antibody-Mediated Expression of Metalloproteinases on Endothelial Cells : Differential Expression of TIMP-1 and ADAM-10 Depends on Antibody Specificity and Isotype
Circ. Res., March 2, 2001; 88(4): 430 - 437.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP